nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Foetal death—Methotrexate—muscle cancer	0.0829	0.0829	CcSEcCtD
Nalbuphine—Speech impairment NOS—Methotrexate—muscle cancer	0.0438	0.0438	CcSEcCtD
Nalbuphine—Respiratory distress—Vincristine—muscle cancer	0.031	0.031	CcSEcCtD
Nalbuphine—Warmth—Doxorubicin—muscle cancer	0.026	0.026	CcSEcCtD
Nalbuphine—Numbness—Vincristine—muscle cancer	0.0238	0.0238	CcSEcCtD
Nalbuphine—Sensory loss—Vincristine—muscle cancer	0.0227	0.0227	CcSEcCtD
Nalbuphine—Tingling sensation—Etoposide—muscle cancer	0.0198	0.0198	CcSEcCtD
Nalbuphine—Numbness—Etoposide—muscle cancer	0.0192	0.0192	CcSEcCtD
Nalbuphine—Sensory loss—Etoposide—muscle cancer	0.0184	0.0184	CcSEcCtD
Nalbuphine—Cardiac arrest—Vincristine—muscle cancer	0.0136	0.0136	CcSEcCtD
Nalbuphine—Swelling—Etoposide—muscle cancer	0.0131	0.0131	CcSEcCtD
Nalbuphine—Redness—Doxorubicin—muscle cancer	0.0123	0.0123	CcSEcCtD
Nalbuphine—Speech disorder—Methotrexate—muscle cancer	0.0111	0.0111	CcSEcCtD
Nalbuphine—Cardiac arrest—Etoposide—muscle cancer	0.011	0.011	CcSEcCtD
Nalbuphine—Depression—Vincristine—muscle cancer	0.011	0.011	CcSEcCtD
Nalbuphine—Feeling hot—Doxorubicin—muscle cancer	0.0105	0.0105	CcSEcCtD
Nalbuphine—Cramp muscle—Etoposide—muscle cancer	0.0104	0.0104	CcSEcCtD
Nalbuphine—Flushing—Dactinomycin—muscle cancer	0.0103	0.0103	CcSEcCtD
Nalbuphine—Bronchospasm—Etoposide—muscle cancer	0.00984	0.00984	CcSEcCtD
Nalbuphine—Hallucination—Vincristine—muscle cancer	0.00984	0.00984	CcSEcCtD
Nalbuphine—Hypoaesthesia—Vincristine—muscle cancer	0.00984	0.00984	CcSEcCtD
Nalbuphine—Sweating increased—Etoposide—muscle cancer	0.00975	0.00975	CcSEcCtD
Nalbuphine—Erythema—Dactinomycin—muscle cancer	0.00964	0.00964	CcSEcCtD
Nalbuphine—Pulmonary oedema—Methotrexate—muscle cancer	0.00851	0.00851	CcSEcCtD
Nalbuphine—Injection site reaction—Doxorubicin—muscle cancer	0.00823	0.00823	CcSEcCtD
Nalbuphine—Hypoaesthesia—Etoposide—muscle cancer	0.00797	0.00797	CcSEcCtD
Nalbuphine—Agitation—Vincristine—muscle cancer	0.00791	0.00791	CcSEcCtD
Nalbuphine—Oedema—Dactinomycin—muscle cancer	0.00786	0.00786	CcSEcCtD
Nalbuphine—Vertigo—Vincristine—muscle cancer	0.00773	0.00773	CcSEcCtD
Nalbuphine—Convulsion—Vincristine—muscle cancer	0.00746	0.00746	CcSEcCtD
Nalbuphine—Flushing—Etoposide—muscle cancer	0.00743	0.00743	CcSEcCtD
Nalbuphine—Hypertension—Vincristine—muscle cancer	0.00743	0.00743	CcSEcCtD
Nalbuphine—Pulmonary oedema—Doxorubicin—muscle cancer	0.00736	0.00736	CcSEcCtD
Nalbuphine—Oedema—Vincristine—muscle cancer	0.00703	0.00703	CcSEcCtD
Nalbuphine—Dysgeusia—Etoposide—muscle cancer	0.00683	0.00683	CcSEcCtD
Nalbuphine—Hyperhidrosis—Vincristine—muscle cancer	0.00679	0.00679	CcSEcCtD
Nalbuphine—Muscle spasms—Etoposide—muscle cancer	0.0067	0.0067	CcSEcCtD
Nalbuphine—Hypotension—Vincristine—muscle cancer	0.00657	0.00657	CcSEcCtD
Nalbuphine—Feeling abnormal—Dactinomycin—muscle cancer	0.00648	0.00648	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00643	0.00643	CcSEcCtD
Nalbuphine—Paraesthesia—Vincristine—muscle cancer	0.00631	0.00631	CcSEcCtD
Nalbuphine—Vertigo—Etoposide—muscle cancer	0.00627	0.00627	CcSEcCtD
Nalbuphine—Body temperature increased—Dactinomycin—muscle cancer	0.00622	0.00622	CcSEcCtD
Nalbuphine—Abdominal pain—Dactinomycin—muscle cancer	0.00622	0.00622	CcSEcCtD
Nalbuphine—Loss of consciousness—Etoposide—muscle cancer	0.00613	0.00613	CcSEcCtD
Nalbuphine—Convulsion—Etoposide—muscle cancer	0.00604	0.00604	CcSEcCtD
Nalbuphine—Hypertension—Etoposide—muscle cancer	0.00602	0.00602	CcSEcCtD
Nalbuphine—Asthma—Methotrexate—muscle cancer	0.00599	0.00599	CcSEcCtD
Nalbuphine—Hypersensitivity—Dactinomycin—muscle cancer	0.00579	0.00579	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Vincristine—muscle cancer	0.00575	0.00575	CcSEcCtD
Nalbuphine—Confusional state—Etoposide—muscle cancer	0.00574	0.00574	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—muscle cancer	0.00571	0.00571	CcSEcCtD
Nalbuphine—Asthenia—Dactinomycin—muscle cancer	0.00564	0.00564	CcSEcCtD
Nalbuphine—Tachycardia—Etoposide—muscle cancer	0.00555	0.00555	CcSEcCtD
Nalbuphine—Abdominal pain—Vincristine—muscle cancer	0.00555	0.00555	CcSEcCtD
Nalbuphine—Body temperature increased—Vincristine—muscle cancer	0.00555	0.00555	CcSEcCtD
Nalbuphine—Hyperhidrosis—Etoposide—muscle cancer	0.0055	0.0055	CcSEcCtD
Nalbuphine—Depression—Methotrexate—muscle cancer	0.00533	0.00533	CcSEcCtD
Nalbuphine—Hypotension—Etoposide—muscle cancer	0.00532	0.00532	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—muscle cancer	0.00519	0.00519	CcSEcCtD
Nalbuphine—Hypersensitivity—Vincristine—muscle cancer	0.00518	0.00518	CcSEcCtD
Nalbuphine—Paraesthesia—Etoposide—muscle cancer	0.00511	0.00511	CcSEcCtD
Nalbuphine—Dyspnoea—Etoposide—muscle cancer	0.00507	0.00507	CcSEcCtD
Nalbuphine—Somnolence—Etoposide—muscle cancer	0.00506	0.00506	CcSEcCtD
Nalbuphine—Asthenia—Vincristine—muscle cancer	0.00504	0.00504	CcSEcCtD
Nalbuphine—Vomiting—Dactinomycin—muscle cancer	0.005	0.005	CcSEcCtD
Nalbuphine—Rash—Dactinomycin—muscle cancer	0.00496	0.00496	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—muscle cancer	0.0048	0.0048	CcSEcCtD
Nalbuphine—Feeling abnormal—Etoposide—muscle cancer	0.00469	0.00469	CcSEcCtD
Nalbuphine—Nausea—Dactinomycin—muscle cancer	0.00467	0.00467	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Etoposide—muscle cancer	0.00465	0.00465	CcSEcCtD
Nalbuphine—Dizziness—Vincristine—muscle cancer	0.00465	0.00465	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—muscle cancer	0.00452	0.00452	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—muscle cancer	0.0045	0.0045	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—muscle cancer	0.0045	0.0045	CcSEcCtD
Nalbuphine—Vomiting—Vincristine—muscle cancer	0.00447	0.00447	CcSEcCtD
Nalbuphine—Rash—Vincristine—muscle cancer	0.00443	0.00443	CcSEcCtD
Nalbuphine—Dermatitis—Vincristine—muscle cancer	0.00443	0.00443	CcSEcCtD
Nalbuphine—Headache—Vincristine—muscle cancer	0.0044	0.0044	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—muscle cancer	0.00423	0.00423	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—muscle cancer	0.00419	0.00419	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—muscle cancer	0.00418	0.00418	CcSEcCtD
Nalbuphine—Nausea—Vincristine—muscle cancer	0.00417	0.00417	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—muscle cancer	0.00413	0.00413	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—muscle cancer	0.00409	0.00409	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—muscle cancer	0.00408	0.00408	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—muscle cancer	0.00403	0.00403	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—muscle cancer	0.00394	0.00394	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—muscle cancer	0.00386	0.00386	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—muscle cancer	0.00376	0.00376	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—muscle cancer	0.00375	0.00375	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—muscle cancer	0.00362	0.00362	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—muscle cancer	0.00362	0.00362	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—muscle cancer	0.00362	0.00362	CcSEcCtD
Nalbuphine—Rash—Etoposide—muscle cancer	0.00359	0.00359	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—muscle cancer	0.00359	0.00359	CcSEcCtD
Nalbuphine—Headache—Etoposide—muscle cancer	0.00357	0.00357	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—muscle cancer	0.00355	0.00355	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—muscle cancer	0.00354	0.00354	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—muscle cancer	0.00351	0.00351	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—muscle cancer	0.00344	0.00344	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—muscle cancer	0.00341	0.00341	CcSEcCtD
Nalbuphine—Nausea—Etoposide—muscle cancer	0.00338	0.00338	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—muscle cancer	0.00332	0.00332	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—muscle cancer	0.0033	0.0033	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—muscle cancer	0.00325	0.00325	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—muscle cancer	0.00324	0.00324	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—muscle cancer	0.00319	0.00319	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—muscle cancer	0.00318	0.00318	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—muscle cancer	0.00313	0.00313	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—muscle cancer	0.00312	0.00312	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—muscle cancer	0.00307	0.00307	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—muscle cancer	0.00306	0.00306	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—muscle cancer	0.00304	0.00304	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—muscle cancer	0.00303	0.00303	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—muscle cancer	0.00301	0.00301	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—muscle cancer	0.003	0.003	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—muscle cancer	0.00298	0.00298	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—muscle cancer	0.00295	0.00295	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—muscle cancer	0.0029	0.0029	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00285	0.00285	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—muscle cancer	0.00281	0.00281	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00279	0.00279	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—muscle cancer	0.00271	0.00271	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—muscle cancer	0.00269	0.00269	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—muscle cancer	0.00269	0.00269	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—muscle cancer	0.00265	0.00265	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—muscle cancer	0.00263	0.00263	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—muscle cancer	0.00262	0.00262	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—muscle cancer	0.0026	0.0026	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—muscle cancer	0.00251	0.00251	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—muscle cancer	0.00245	0.00245	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—muscle cancer	0.00243	0.00243	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—muscle cancer	0.00241	0.00241	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—muscle cancer	0.00235	0.00235	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—muscle cancer	0.00233	0.00233	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—muscle cancer	0.00225	0.00225	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—muscle cancer	0.00217	0.00217	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—muscle cancer	0.00217	0.00217	CcSEcCtD
Nalbuphine—Rash—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Nalbuphine—Headache—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—muscle cancer	0.00209	0.00209	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—muscle cancer	0.00202	0.00202	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—muscle cancer	0.00195	0.00195	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—muscle cancer	0.00188	0.00188	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
